CHRONIC RENAL FAILURE

This study tested a drug called sevelamer carbonate in 98 people with chronic kidney disease (stages 3b-4) who were not on dialysis. The goal was to see if it could lower a hormone called FGF-23, which is often high in kidney disease and linked to bone and heart problems. Partici…

This study checked the safety of a new dialysis filter called ELISIO™-HX in 22 adults with kidney failure who were already on dialysis. The main goal was to make sure the filter did not lower blood protein (albumin) levels, while also improving removal of certain waste products. …

This study tested a special dialysis fluid called icodextrin in 439 adults with chronic kidney failure who use peritoneal dialysis. The goal was to see if it works better than standard glucose fluid at preventing treatment failure or death. Results will help doctors choose the be…

This study looked at 178 people with advanced cancer, chronic kidney disease, or chronic lung disease to find out when they need palliative care. Researchers used special scores to see if care was given at the right time. No extra treatments or visits were added—just observation …

This study aimed to find the genetic causes of certain inherited kidney diseases that run in families. Researchers studied 225 adults with chronic kidney failure and gout, looking for mutations in known genes and searching for new ones. The goal was to better understand these rar…

This study looked at tiny particles called extracellular vesicles found in urine to see if they can help tell the difference between healthy kidneys and chronic kidney disease. Researchers measured the number of these particles in 143 adults, including healthy volunteers and pati…

This study looked at how two medications—dapagliflozin and balcinrenone—affect the way the body manages water, salt, and energy in people over 50 with stage 3 chronic kidney disease. Over 100 participants took one of four treatments (dapagliflozin alone, balcinrenone alone, both,…